AMLX compared with RLAY: revenue, margins and what each company keeps, and the suppliers and customers both name

AMLXAmylyx Pharmaceuticals, Inc.

Mkt capRevenueRevenue

RLAYRelay Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMLXAmylyx Pharmaceuticals, Inc.

RLAYRelay Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

AMLXwithRLAY

×0.26co-movement · RLAY on AMLX · 500d

r 0.31scale to r 0.75

Shared co-movers3with AMLXwith RLAY

XNCRXencor Incr 0.38r 0.45

IMNMImmunome Inc.r 0.37r 0.48

SYRESpyre Therapeutics, Inc.r 0.36r 0.38

AMLX, solidRLAY, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

AMLXAmylyx Pharmaceuticals, Inc.

28.03▼−2.86%· post 28.04

Mkt cap$3.2BRevenue$416,000Q3 FY24

RLAYRelay Therapeutics, Inc.

17.28▼−5.85%· post 17.28

ClosedNov 2 '26

Mkt cap$4.0BRevenue$350,000Q2 FY26

Compare

ClosedNov 2 '26

AMLXAmylyx Pharmaceuticals, Inc.

RLAYRelay Therapeutics, Inc.

28.03▼−2.86%post 28.04

Price

17.28▼−5.85%post 17.28

$3.2B

Mkt cap

$4.0B

Q3 FY24$416,000

Revenue

$350,000Q2 FY26

AMLX28.03▼−2.86%vsRLAY17.28▼−5.85%ClosedNov 2 '26